Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from MLSP: A bioinformatics tool for predicting molecular subtypes and prognosis in patients with breast cancer. Local targets link to admitted publications; unresolved targets remain external evidence.
10.3322/caac.21442
10.3322/caac.21442 · External reference
10.3322/caac.21551
10.3322/caac.21551 · External reference
Unresolved reference
External reference
10.1016/s1470-2045(13)70567-9
10.1016/s1470-2045(13)70567-9 · External reference
10.1186/s13059-014-0431-1
10.1186/s13059-014-0431-1 · External reference
10.1016/j.cell.2015.09.033
10.1016/j.cell.2015.09.033 · External reference
10.1038/35021093
10.1038/35021093 · External reference
10.5306/wjco.v5.i3.382
10.5306/wjco.v5.i3.382 · External reference
10.1073/pnas.191367098
10.1073/pnas.191367098 · External reference
10.1158/0008-5472.can-11-3218
10.1158/0008-5472.can-11-3218 · External reference
10.1126/science.1129139
10.1126/science.1129139 · External reference
Prognostic significance of B-cells and pSTAT3 in patients with ovarian cancer
10.1371/journal.pone.0054029 · 2013 · External reference
10.1056/nejmoa020177
10.1056/nejmoa020177 · External reference
10.1039/c8mo00128f
10.1039/c8mo00128f · External reference
10.1016/j.ygeno.2019.08.021
10.1016/j.ygeno.2019.08.021 · External reference
10.1016/s1470-2045(17)30904-x
10.1016/s1470-2045(17)30904-x · External reference
Tumor-infiltrating CD8 T cells predict clinical breast cancer outcomes in young women
2020 · External reference
10.1146/annurev-med-051013-052304
10.1146/annurev-med-051013-052304 · External reference
Spatial characterization of tumor-infiltrating lymphocytes and breast cancer progression
10.3390/cancers14092148 · 2022 · External reference
Clinical significance of tumor-infiltrating lymphocytes in neoplastic progression and lymph node metastasis of human breast cancer
10.1016/j.breast.2008.06.001 · 2008 · External reference
10.1016/j.molmed.2019.04.004
10.1016/j.molmed.2019.04.004 · External reference
10.1016/j.tips.2019.01.005
10.1016/j.tips.2019.01.005 · External reference
10.1038/ng.2760
10.1038/ng.2760 · External reference
A Pyroptosis-related gene signature predicts prognosis and immune microenvironment for breast cancer based on computational biology techniques
10.3389/fgene.2022.801056 · 2022 · External reference
A Ferroptosis-Related lncRNAs signature predicts prognosis and immune microenvironment for breast cancer
10.3389/fmolb.2021.678877 · 2021 · External reference
Classification of breast cancer nottingham prognostic index using high-dimensional embedding and residual neural network
2022 · External reference
A novel approach for identifying relevant genes for breast cancer survivability on specific therapies
2018 · External reference
10.1016/j.cell.2017.10.049
10.1016/j.cell.2017.10.049 · External reference
10.1038/nature10983
10.1038/nature10983 · External reference
An aging-related gene signature-based model for risk stratification and prognosis prediction in breast cancer
10.2147/ijwh.s334756 · 2021 · External reference
Construction and identification of a novel 5-gene signature for predicting the prognosis in breast cancer
10.3389/fmed.2021.669931 · 2021 · External reference
10.7717/peerj.12276
10.7717/peerj.12276 · External reference
Analysing a novel RNA-binding-protein-related prognostic signature highly expressed in breast cancer
2021 · External reference
Identification and prognostic value exploration of cyclophosphamide (cytoxan)-centered chemotherapy response-associated genes in breast cancer
10.1089/dna.2021.0077 · 2021 · External reference
Identification of a prognostic chemoresistance-related gene signature associated with immune microenvironment in breast cancer
10.1080/21655979.2021.1977768 · 2021 · External reference
Integrated analysis of copy number variation, microsatellite instability, and tumor mutation burden identifies an 11-gene signature predicting survival in breast cancer
10.3389/fcell.2021.721505 · 2021 · External reference
A novel seven gene signature-based prognostic model to predict distant metastasis of lymph node-negative triple-negative breast cancer
10.3389/fonc.2021.746763 · 2021 · External reference
Identification of a novel glycolysis-related signature to predict the prognosis of patients with breast cancer
10.1186/s12957-021-02409-w · 2021 · External reference
Prognostic value of a glycolytic signature and its regulation by Y-Box-binding protein 1 in triple-negative breast cancer
2021 · External reference
Identification of a novel immune-related prognostic signature associated with tumor microenvironment for breast cancer
10.1016/j.intimp.2021.108122 · 2021 · External reference
Identification and validation of a ferroptosis-related gene signature predictive of prognosis in breast cancer
10.18632/aging.203472 · 2021 · External reference
Identification of a hypoxia-related molecular classification and hypoxic tumor microenvironment signature for predicting the prognosis of patients with triple-negative breast cancer
10.3389/fonc.2021.700062 · 2021 · External reference
Risk signature of cancer-associated fibroblast-secreted cytokines associates with clinical outcomes of breast cancer
10.3389/fonc.2021.628677 · 2021 · External reference
A combined hypoxia and immune gene signature for predicting survival and risk stratification in triple-negative breast cancer
10.18632/aging.203360 · 2021 · External reference
Identification of a Three-RNA Binding Proteins (RBPs) signature predicting prognosis for breast cancer
10.3389/fonc.2021.663556 · 2021 · External reference
Identification and validation of immune-related methylation clusters for predicting immune activity and prognosis in breast cancer
10.3389/fimmu.2021.704557 · 2021 · External reference
Development of a novel prognostic signature based on antigen processing and presentation in patients with breast cancer
10.3389/pore.2021.600727 · 2021 · External reference
Identification of a novel transcription factor prognostic index for breast cancer
10.3389/fonc.2021.666505 · 2021 · External reference
Bioinformatics reveal macrophages marker genes signature in breast cancer to predict prognosis
2021 · External reference
Identification and validation of a robust autophagy-related molecular model for predicting the prognosis of breast cancer patients
2021 · External reference
The m(6)A-related gene signature for predicting the prognosis of breast cancer
10.7717/peerj.11561 · 2021 · External reference
A histone acetylation modulator gene signature for classification and prognosis of breast cancer
10.3390/curroncol28010091 · 2021 · External reference
A risk prediction model for breast cancer based on immune genes related to early growth response proteins family
10.3389/fmolb.2020.616547 · 2020 · External reference
Identification of a 15-pseudogene based prognostic signature for predicting survival and antitumor immune response in breast cancer
10.18632/aging.103735 · 2020 · External reference
A seven-nuclear receptor-based prognostic signature in breast cancer
10.1007/s12094-020-02517-1 · 2021 · External reference
Identification and validation of an immunological expression-based prognostic signature in breast cancer
10.3389/fgene.2020.00912 · 2020 · External reference
Gene signatures and prognostic analyses of the Tob/BTG pituitary tumor-transforming gene (PTTG) family in clinical breast cancer patients
10.7150/ijms.49652 · 2020 · External reference
Multi-gene signature of microcalcification and risk prediction among Taiwanese breast cancer
10.1038/s41598-020-74982-1 · 2020 · External reference
Identification of a 9-gene prognostic signature for breast cancer
2020 · External reference
Prediction of overall survival among female patients with breast cancer using a prognostic signature based on 8 DNA repair-related genes
10.1001/jamanetworkopen.2020.14622 · 2020 · External reference
Five-mRNA signature for the prognosis of breast cancer based on the ceRNA network
10.1155/2020/9081852 · 2020 · External reference
Exploration the significance of a novel immune-related gene signature in prognosis and immune microenvironment of breast cancer
10.3389/fonc.2020.01211 · 2020 · External reference
Establishment of a novel CNV-related prognostic signature predicting prognosis in patients with breast cancer
10.1186/s13048-021-00823-y · 2021 · External reference
10.1093/bioinformatics/btq170
10.1093/bioinformatics/btq170 · External reference
An integrative analysis of the age-associated multi-omic landscape across cancers
10.1038/s41467-021-22560-y · 2021 · External reference
10.1186/1471-2105-14-7
10.1186/1471-2105-14-7 · External reference
m(6)A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer
10.1186/s12943-020-01170-0 · 2020 · External reference
10.1016/j.celrep.2016.12.019
10.1016/j.celrep.2016.12.019 · External reference
10.1038/nature08460
10.1038/nature08460 · External reference
10.1093/nar/gkv007
10.1093/nar/gkv007 · External reference
The genetic algorithm-aided three-stage ensemble learning method identified a robust survival risk score in patients with glioma
2022 · External reference
The molecular landscape of Asian breast cancers reveals clinically relevant population-specific differences
10.1038/s41467-020-20173-5 · 2020 · External reference
Comprehensive omic characterization of breast cancer in Mexican-Hispanic women
10.1038/s41467-021-22478-5 · 2021 · External reference
Postpartum breast cancer has a distinct molecular profile that predicts poor outcomes
10.1038/s41467-021-26505-3 · 2021 · External reference
Comprehensive analysis of pyroptosis-related genes and tumor microenvironment infiltration characterization in breast cancer
10.3389/fimmu.2021.748221 · 2021 · External reference
Identification of N6-methyladenosine-related lncrnas for predicting overall survival and clustering of a potentially novel molecular subtype of breast cancer
10.3389/fonc.2021.742944 · 2021 · External reference
A novel risk model based on lipid metabolism-associated genes predicts prognosis and indicates immune microenvironment in breast cancer
10.3389/fcell.2021.691676 · 2021 · External reference
10.1038/embor.2012.61
10.1038/embor.2012.61 · External reference
Integrated analysis of genetic ancestry and genomic alterations across cancers
10.1016/j.ccell.2018.08.019 · 2018 · External reference
Tumor aneuploidy correlates with markers of immune evasion and with reduced response to immunotherapy
10.1126/science.aaf8399 · 2017 · External reference
10.1038/nrc3239
10.1038/nrc3239 · External reference
Tumor immunological phenotype signature-based high-throughput screening for the discovery of combination immunotherapy compounds
2021 · External reference
10.1158/0008-5472.can-19-3260
10.1158/0008-5472.can-19-3260 · External reference
10.1158/1535-7163.mct-17-0386
10.1158/1535-7163.mct-17-0386 · External reference
10.1126/science.1132939
10.1126/science.1132939 · External reference
10.1038/s41568-020-0266-x
10.1038/s41568-020-0266-x · External reference
Breast cancer heterogeneity and response to novel therapeutics
2020 · External reference
Chidamide combined with doxorubicin induced p53-driven cell cycle arrest and cell apoptosis reverse multidrug resistance of breast cancer
10.3389/fonc.2021.614458 · 2021 · External reference
Histone deacetylase 2 knockout suppresses immune escape of triple-negative breast cancer cells via downregulating PD-L1 expression
10.1038/s41419-021-04047-2 · 2021 · External reference
PARP3 inhibitors ME0328 and olaparib potentiate vinorelbine sensitization in breast cancer cell lines
10.1007/s10549-018-4888-6 · 2018 · External reference
10.1038/s41418-018-0233-1
10.1038/s41418-018-0233-1 · External reference
